MIR6859-4

Across TCGA pan-cancer cohorts, MIR6859-4 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MIR6859-4 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher MIR6859-4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6859-4 expression acts as an unfavorable survival marker.

THYM and LIHC are the cancer types where MIR6859-4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
LIHC	DFS	Median	All	0.043	0.527	<.001	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR6859-4–THYM (OS)

Open the THYM breakdown →